137 related articles for article (PubMed ID: 6597126)
21. [Cytotoxic action of natural killer cells on human tumor cells].
Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
[TBL] [Abstract][Full Text] [Related]
22. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities.
Abrams SI; Brahmi Z
J Immunol; 1988 Mar; 140(6):2090-5. PubMed ID: 3279127
[TBL] [Abstract][Full Text] [Related]
23. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
Cosentino LM; Cathcart MK
Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
[TBL] [Abstract][Full Text] [Related]
24. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
[TBL] [Abstract][Full Text] [Related]
25. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
Thiele DL; Lipsky PE
J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
27. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
28. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
Rönnblom L; Ramstedt U; Alm GV
Eur J Immunol; 1983 Jun; 13(6):471-6. PubMed ID: 6574913
[TBL] [Abstract][Full Text] [Related]
29. Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutinin.
Ogawara M; Utsugi T; Yamazaki M; Sone S
Jpn J Cancer Res; 1985 Nov; 76(11):1107-14. PubMed ID: 2418002
[TBL] [Abstract][Full Text] [Related]
30. Interactions between fresh human blood monocytes and tumor targets at the single cell level: binding and morphological characteristics.
Muse KE; Koren HS
J Reticuloendothel Soc; 1982 Nov; 32(5):323-37. PubMed ID: 6962303
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
32. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
34. Monocyte-mediated augmentation of human natural cell-mediated cytotoxicity.
Bloom ET; Babbitt JT
Cell Immunol; 1985 Mar; 91(1):21-32. PubMed ID: 3855702
[TBL] [Abstract][Full Text] [Related]
35. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
Abrams SI; Brahmi Z
Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
[TBL] [Abstract][Full Text] [Related]
36. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
Hall RE; Muchmore AV; Blaese RM
J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
[TBL] [Abstract][Full Text] [Related]
37. Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: biochemical, functional, and serological characterization of cytotoxins produced by peripheral blood monocytes isolated by counterflow elutriation.
Klostergaard J; Foster WA; Hamilton DA; Turpin J; Lopez-Berestein G
Cancer Res; 1986 Jun; 46(6):2871-5. PubMed ID: 3698012
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide exposure during purification of human monocytes by adherence increases their recovery and cytolytic activity.
Chen AR; Whitaker FS; McKinnon KP; Koren HS
Cell Immunol; 1986 Nov; 103(1):120-32. PubMed ID: 3802206
[TBL] [Abstract][Full Text] [Related]
39. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
Hagner G
Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
[TBL] [Abstract][Full Text] [Related]
40. The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.
Espevik T; Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1986 Feb; 57(2):255-9. PubMed ID: 3081437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
